4//SEC Filing
Anders Jack 4
Accession 0001610717-25-000404
CIK 0001628171other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:16 PM ET
Size
8.0 KB
Accession
0001610717-25-000404
Insider Transaction Report
Form 4
Anders Jack
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-25$17.00/sh+5,418$92,106→ 116,412 total - Sale
Common Stock
2025-11-25$74.00/sh−5,418$400,932→ 110,994 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−5,418→ 0 totalExercise: $17.00From: 2024-02-12Exp: 2030-02-11→ Common Stock (5,418 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.
- [F2]Includes 48,275 restricted stock units.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001800668
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:16 PM ET
- Size
- 8.0 KB